SCN9A and diabetic neuropathy: Preclinical studies showed that in diabetic animals there is an increase in TNF-α concentration in serum, and this in turn induces an increase in the expression of the sodium channel NaV1.7, which results in the sensitization of nerve endings and implicitly the development of diabetic neuropathy.